Termination of unwanted pregnancy Pregnancy and Childbirth Medical abortion
Conditions
Interventions
Women randomised to STOP:
All nulliparous women and multiparous women greater than 17 weeks' gestation were primed with Gemeprost 1 mg vaginally 3 and 6 hours prior to the anticipated time of STOP. Mu
Sponsors
Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women accepted for termination of pregnancy (TOP) under clause C of the Human Fertilisation and Embryology Act (1990) amendment of the Abortion Act (1967) 2. Pregnancies between 13+0 and 19+6 weeks' gestation at the time of abortion 3. Aged over 16 years; women under 16 years of age were eligible for inclusion if deemed Fraser competent by the clinical practitioner and where a parent or guardian was present and also willing to give written consent
Exclusion criteria
Exclusion criteria: 1. Foetal congenital abnormality 2. Medical disease precluding MTOP 3. Unable to speak English (less than 5% of women presenting for TOP)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of Event Scale (IES) at two weeks after the procedure. This 15 item scale has 7 intrusion and 8 avoidance items. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clinical effectiveness of procedure, measured at two weeks post-procedure 2. Complications, measured at two weeks post-procedure 3. Procedure specific symptoms, measured at two weeks post-procedure 4. Acceptability, measured at two weeks post-procedure 5. General health Questionnaire-12 item (GHQ-12), measured at baseline and two weeks post-procedure 6. Hospital Anxiety and Depression Scale (HADS), measured at baseline and two weeks post-procedure 7. Satisfaction with care received before during and after procedure (excellent/very good/good/fair/poor), measured at two weeks post-procedure | — |
Countries
United Kingdom
Outcome results
None listed